Skip to main content
Premium Trial:

Request an Annual Quote

Veracyte: Rebecca Chambers

Veracyte has appointed Rebecca Chambers as executive VP and CFO. She will join the company July 19, reporting to Marc Stapley, Veracyte’s CEO. Chambers has extensive healthcare leadership experience, most recently serving as CFO for Outset Medical, a publicly traded medical technology company focused on reducing the cost and complexity of dialysis. Prior to that, she was with Illumina, where she served in a number of financial roles including VP of financial planning & analysis and VP of investor relations and treasury. Previously, Chambers served as head of investor relations and corporate communications at Myriad Genetics, and before that, she held various roles in investor relations at Life Technologies. She holds a BS from John Carroll University and an MBA from The S.C. Johnson Graduate School of Management at Cornell University.

The Scan

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.

Effectiveness May Decline, Data From Israel Suggests

The New York Times reports that new Israeli data suggests a decline in Pfizer-BioNTech SARS-CoV-2 vaccine effectiveness against Delta variant infection, though protection against severe disease remains high.

To See Future Risk

Slate looks into the use of polygenic risk scores in embryo screening.

PLOS Papers on Methicillin-Resistant Staphylococcus, Bone Marrow Smear Sequencing, More

In PLOS this week: genomic analysis of methicillin-resistant Staphylococcus pseudintermedius, archived bone marrow sequencing, and more.